CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered ...
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options ...
CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...
CVS Health does a 180. On May 28, CVS Caremark, the pharmacy benefits manager (PBM) under CVS Health's umbrella, announced it ...
In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a win for GLP-1 patients.
CVS Caremark, one of America’s most powerful pharmacy benefit managers, will begin covering more GLP-1 medications again ...
CVS Health’s pharmacy benefit manager (PBM), CVS Caremark, joined forces with GoodRx to launch a prescription drug cost-saving program Wednesday. The Caremark Cost Saver gives CVS Caremark members the ...
Retired social worker Nina Nestor got an all-too-familiar phone call last week: Her prescription refill was ready at her CVS store in San Clemente. Trouble is, the 83-year-old cancer patient didn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results